Prime Medicine, Inc. (PRME)
3.58
-0.32
(-8.21%)
USD |
NASDAQ |
Oct 08, 16:00
3.59
+0.01
(+0.28%)
After-Hours: 20:00
Prime Medicine Price to Book Value : 16.25 for Oct. 8, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 17.71 |
| October 06, 2026 | 15.89 |
| October 05, 2026 | 14.57 |
| October 02, 2026 | 13.53 |
| October 01, 2026 | 13.57 |
| September 30, 2026 | 13.87 |
| September 29, 2026 | 14.03 |
| September 28, 2026 | 13.05 |
| September 25, 2026 | 13.17 |
| September 24, 2026 | 13.94 |
| September 23, 2026 | 14.21 |
| September 22, 2026 | 16.07 |
| September 21, 2026 | 14.48 |
| September 18, 2026 | 14.17 |
| September 17, 2026 | 14.26 |
| September 16, 2026 | 13.62 |
| September 15, 2026 | 14.26 |
| September 14, 2026 | 14.44 |
| September 11, 2026 | 14.21 |
| September 10, 2026 | 15.21 |
| September 09, 2026 | 15.75 |
| September 08, 2026 | 16.16 |
| September 04, 2026 | 16.80 |
| September 03, 2026 | 16.84 |
| September 02, 2026 | 16.66 |
| Date | Value |
|---|---|
| September 01, 2026 | 16.21 |
| August 31, 2026 | 16.30 |
| August 28, 2026 | 16.39 |
| August 27, 2026 | 16.53 |
| August 26, 2026 | 16.25 |
| August 25, 2026 | 16.84 |
| August 24, 2026 | 14.76 |
| August 21, 2026 | 15.39 |
| August 20, 2026 | 14.71 |
| August 19, 2026 | 16.07 |
| August 18, 2026 | 13.85 |
| August 17, 2026 | 14.39 |
| August 14, 2026 | 14.03 |
| August 13, 2026 | 14.39 |
| August 12, 2026 | 14.53 |
| August 11, 2026 | 14.80 |
| August 10, 2026 | 14.30 |
| August 07, 2026 | 13.98 |
| August 06, 2026 | 13.39 |
| August 05, 2026 | 13.98 |
| August 04, 2026 | 13.53 |
| August 03, 2026 | 12.76 |
| July 31, 2026 | 13.26 |
| July 30, 2026 | 13.71 |
| July 29, 2026 | 13.76 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Beam Therapeutics, Inc. | 2.379 |
| Twist Bioscience Corp. | 21.37 |
| Intellia Therapeutics, Inc. | 2.417 |
| Q32 Bio, Inc. | 1.818 |
| Revolution Medicines, Inc. | 15.47 |
Price to Book Value Related Metrics
| PS Ratio | 152.79 |
| Price | 3.58 |
| Earnings Yield | -30.32% |
| Market Cap | 647.04M |